A citation-based method for searching scientific literature


List of co-cited articles
3 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



The neurology of mTOR.
Jonathan O Lipton, Mustafa Sahin. Neuron 2014
346
40

Rediscovering the value of families for psychiatric genetics research.
David C Glahn, Vishwajit L Nimgaonkar, Henriette Raventós, Javier Contreras, Andrew M McIntosh, Pippa A Thomson, Assen Jablensky, Nina S McCarthy, Jac C Charlesworth, Nicholas B Blackburn,[...]. Mol Psychiatry 2019
24
40

Adolescent cannabis use, change in neurocognitive function, and high-school graduation: A longitudinal study from early adolescence to young adulthood.
Natalie Castellanos-Ryan, Jean-Baptiste Pingault, Sophie Parent, Frank Vitaro, Richard E Tremblay, Jean R Séguin. Dev Psychopathol 2017
35
20

Association analysis of AKT1 and schizophrenia in a UK case control sample.
Nadine Norton, Hywel J Williams, Sarah Dwyer, Liam Carroll, Tim Peirce, Valentina Moskvina, Ricardo Segurado, Ivan Nikolov, Nigel M Williams, Masashi Ikeda,[...]. Schizophr Res 2007
49
20

Catechol-O-methyltransferase Val158Met modulation of prefrontal-parietal-striatal brain systems during arithmetic and temporal transformations in working memory.
Hao-Yang Tan, Qiang Chen, Terry E Goldberg, Venkata S Mattay, Andreas Meyer-Lindenberg, Daniel R Weinberger, Joseph H Callicott. J Neurosci 2007
114
20

Evaluating the dopamine hypothesis of schizophrenia in a large-scale genome-wide association study.
Alexis C Edwards, Silviu-Alin Bacanu, Tim B Bigdeli, Arden Moscati, Kenneth S Kendler. Schizophr Res 2016
20
20

Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review.
Theresa H M Moore, Stanley Zammit, Anne Lingford-Hughes, Thomas R E Barnes, Peter B Jones, Margaret Burke, Glyn Lewis. Lancet 2007
20

Confirmation that the AKT1 (rs2494732) genotype influences the risk of psychosis in cannabis users.
Marta Di Forti, Conrad Iyegbe, Hannah Sallis, Anna Kolliakou, M Aurora Falcone, Alessandra Paparelli, Miriam Sirianni, Caterina La Cascia, Simona A Stilo, Tiago Reis Marques,[...]. Biol Psychiatry 2012
142
20


Effects of cannabis and psychosis vulnerability in daily life: an experience sampling test study.
H Verdoux, C Gindre, F Sorbara, M Tournier, J D Swendsen. Psychol Med 2003
122
20

Delta-9-tetrahydrocannabinol effects in schizophrenia: implications for cognition, psychosis, and addiction.
Deepak Cyril D'Souza, Walid Michel Abi-Saab, Steven Madonick, Kimberlee Forselius-Bielen, Anne Doersch, Gabriel Braley, Ralitza Gueorguieva, Thomas B Cooper, John Harrison Krystal. Biol Psychiatry 2005
380
20

Genetic assessment of additional endophenotypes from the Consortium on the Genetics of Schizophrenia Family Study.
Tiffany A Greenwood, Laura C Lazzeroni, Monica E Calkins, Robert Freedman, Michael F Green, Raquel E Gur, Ruben C Gur, Gregory A Light, Keith H Nuechterlein, Ann Olincy,[...]. Schizophr Res 2016
39
20

Dopamine and Working Memory: Genetic Variation, Stress and Implications for Mental Health.
Kristel Klaus, Kyla Pennington. Curr Top Behav Neurosci 2019
3
33

Cannabis use and neurocognitive functioning in a non-clinical sample of users.
April D Thames, Natalie Arbid, Philip Sayegh. Addict Behav 2014
51
20

Unravelling the activation mechanisms of protein kinase B/Akt.
Michael P Scheid, James R Woodgett. FEBS Lett 2003
312
20

Acute and Chronic Effects of Cannabinoids on Human Cognition-A Systematic Review.
Samantha J Broyd, Hendrika H van Hell, Camilla Beale, Murat Yücel, Nadia Solowij. Biol Psychiatry 2016
271
20


The heritability of general cognitive ability increases linearly from childhood to young adulthood.
C M A Haworth, M J Wright, M Luciano, N G Martin, E J C de Geus, C E M van Beijsterveldt, M Bartels, D Posthuma, D I Boomsma, O S P Davis,[...]. Mol Psychiatry 2010
249
20

Genetic variation in AKT1 is linked to dopamine-associated prefrontal cortical structure and function in humans.
Hao-Yang Tan, Kristin K Nicodemus, Qiang Chen, Zhen Li, Jennifer K Brooke, Robyn Honea, Bhaskar S Kolachana, Richard E Straub, Andreas Meyer-Lindenberg, Yoshitasu Sei,[...]. J Clin Invest 2008
135
20



Effective connectivity of AKT1-mediated dopaminergic working memory networks and pharmacogenetics of anti-dopaminergic treatment.
Hao Yang Tan, Anthony G Chen, Bhaskar Kolachana, Jose A Apud, Venkata S Mattay, Joseph H Callicott, Qiang Chen, Daniel R Weinberger. Brain 2012
43
20

Cognitive impairment in schizophrenia.
Richard S E Keefe, Philip D Harvey. Handb Exp Pharmacol 2012
221
20

Cannabis use and cognitive function in first episode psychosis: differential effect of heavy use.
Christian Núñez, Susana Ochoa, Elena Huerta-Ramos, Iris Baños, Ana Barajas, Montserrat Dolz, Bernardo Sánchez, Núria Del Cacho, Judith Usall. Psychopharmacology (Berl) 2016
16
20

Haploview: analysis and visualization of LD and haplotype maps.
J C Barrett, B Fry, J Maller, M J Daly. Bioinformatics 2005
20

Process of adaptation to Spanish of the Community Assessment of Psychic Experiences (CAPE).
Agnés Ros-Morente, Raúl Vilagra-Ruiz, Gisela Rodriguez-Hansen, Johanna H Wigman, Neus Barrantes-Vidal. Actas Esp Psiquiatr 2011
17
20

PKB/AKT: functional insights from genetic models.
M P Scheid, J R Woodgett. Nat Rev Mol Cell Biol 2001
484
20

Opposite Cannabis-Cognition Associations in Psychotic Patients Depending on Family History.
Ana González-Pinto, Itxaso González-Ortega, Susana Alberich, Sonia Ruiz de Azúa, Miguel Bernardo, Miquel Bioque, Bibiana Cabrera, Iluminada Corripio, Celso Arango, Antonio Lobo,[...]. PLoS One 2016
13
20


The effects of cannabis use on neurocognition in schizophrenia: a meta-analysis.
Rachel A Rabin, Konstantine K Zakzanis, Tony P George. Schizophr Res 2011
90
20

Neurocognitive functioning and cannabis use in schizophrenia.
Aviv Segev, Shaul Lev-Ran. Curr Pharm Des 2012
8
20

An integrated map of genetic variation from 1,092 human genomes.
Goncalo R Abecasis, Adam Auton, Lisa D Brooks, Mark A DePristo, Richard M Durbin, Robert E Handsaker, Hyun Min Kang, Gabor T Marth, Gil A McVean. Nature 2012
20



Lifetime cannabis use and cognition in patients with schizophrenia spectrum disorders and their unaffected siblings.
Ana M Sánchez-Torres, Virginia Basterra, Araceli Rosa, Lourdes Fañanás, Amalia Zarzuela, Berta Ibáñez, Víctor Peralta, Manuel J Cuesta. Eur Arch Psychiatry Clin Neurosci 2013
16
20

Genome-wide association studies establish that human intelligence is highly heritable and polygenic.
G Davies, A Tenesa, A Payton, J Yang, S E Harris, D Liewald, X Ke, S Le Hellard, A Christoforou, M Luciano,[...]. Mol Psychiatry 2011
338
20


Meta-analysis of the Association Between the Level of Cannabis Use and Risk of Psychosis.
Arianna Marconi, Marta Di Forti, Cathryn M Lewis, Robin M Murray, Evangelos Vassos. Schizophr Bull 2016
256
20

The AKT1 gene is associated with attention and brain morphology in schizophrenia.
Kazutaka Ohi, Ryota Hashimoto, Yuka Yasuda, Motoyuki Fukumoto, Kiyotaka Nemoto, Takashi Ohnishi, Hidenaga Yamamori, Hidetoshi Takahashi, Naomi Iike, Kouzin Kamino,[...]. World J Biol Psychiatry 2013
19
20

AKT1 is associated with schizophrenia across multiple symptom dimensions in the Irish study of high density schizophrenia families.
Dawn L Thiselton, Vladimir I Vladimirov, Po-Hsiu Kuo, Joseph McClay, Brandon Wormley, Ayman Fanous, Francis A O'Neill, Dermot Walsh, Edwin J C G Van den Oord, Kenneth S Kendler,[...]. Biol Psychiatry 2008
111
20

The Akt-GSK-3 signaling cascade in the actions of dopamine.
Jean-Martin Beaulieu, Raul R Gainetdinov, Marc G Caron. Trends Pharmacol Sci 2007
293
20

Preliminary report of biological basis of sensitivity to the effects of cannabis on psychosis: AKT1 and DAT1 genotype modulates the effects of δ-9-tetrahydrocannabinol on midbrain and striatal function.
S Bhattacharyya, Z Atakan, R Martin-Santos, J A Crippa, J Kambeitz, D Prata, S Williams, M Brammer, D A Collier, P K McGuire. Mol Psychiatry 2012
86
20

Epigenetic codes in cognition and behaviour.
Johannes Gräff, Isabelle M Mansuy. Behav Brain Res 2008
153
20

Heritability of Neuropsychological Measures in Schizophrenia and Nonpsychiatric Populations: A Systematic Review and Meta-analysis.
Gabriëlla A M Blokland, Raquelle I Mesholam-Gately, Timothea Toulopoulou, Elisabetta C Del Re, Max Lam, Lynn E DeLisi, Gary Donohoe, James T R Walters, Larry J Seidman, Tracey L Petryshen. Schizophr Bull 2017
36
20

Protein kinase B (AKT1) genotype mediates sensitivity to cannabis-induced impairments in psychomotor control.
S Bhattacharyya, C Iyegbe, Z Atakan, R Martin-Santos, J A Crippa, X Xu, S Williams, M Brammer, K Rubia, D Prata,[...]. Psychol Med 2014
31
20

Cognitive intermediate phenotype and genetic risk for psychosis.
Winifred Mark, Timothea Toulopoulou. Curr Opin Neurobiol 2016
14
20

Genome-wide Association of Endophenotypes for Schizophrenia From the Consortium on the Genetics of Schizophrenia (COGS) Study.
Tiffany A Greenwood, Laura C Lazzeroni, Adam X Maihofer, Neal R Swerdlow, Monica E Calkins, Robert Freedman, Michael F Green, Gregory A Light, Caroline M Nievergelt, Keith H Nuechterlein,[...]. JAMA Psychiatry 2019
19
20

An experimental study of catechol-o-methyltransferase Val158Met moderation of delta-9-tetrahydrocannabinol-induced effects on psychosis and cognition.
Cécile Henquet, Araceli Rosa, Lydia Krabbendam, Sergi Papiol, Lourdes Fananás, Marjan Drukker, Johannes G Ramaekers, Jim van Os. Neuropsychopharmacology 2006
214
20



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.